{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:54:43Z","timestamp":1772236483705,"version":"3.50.1"},"reference-count":33,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.206212","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T10:13:31Z","timestamp":1740651211000},"source":"Crossref","is-referenced-by-count":0,"title":["Variability in radiotherapy outcomes across cancer types: a comparative study of glioblastoma multiforme and low-grade gliomas"],"prefix":"10.18632","author":[{"given":"Alexander","family":"Veviorskiy","sequence":"first","affiliation":[{"name":"Insilico Medicine AI Limited, Abu Dhabi, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garik V.","family":"Mkrtchyan","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreyan N.","family":"Osipov","sequence":"additional","affiliation":[{"name":"CANDLE Synchrotron Research Institute, Yerevan 0040, Armenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeny","family":"Izumchenko","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL 60637, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan V.","family":"Ozerov","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL 60637, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Aliper","sequence":"additional","affiliation":[{"name":"Insilico Medicine AI Limited, Abu Dhabi, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Zhavoronkov","sequence":"additional","affiliation":[{"name":"Insilico Medicine AI Limited, Abu Dhabi, UAE"},{"name":"Insilico Medicine Hong Kong Limited, Hong Kong Science and Technology Park, Hong Kong"},{"name":"Insilico Medicine Canada Inc., Ren\u00e9-L\u00e9vesque Blvd W, Montreal, Quebec H3B 4W8, Canada"},{"name":"Buck Institute for Research on Aging, Novato, CA 94945, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Scheibye-Knudsen","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3390\/cancers12040957","article-title":"Pan-Cancer Analysis of Radiotherapy Benefits and Immune Infiltration in Multiple Human Cancers.","volume":"1","author":"Zhao","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2","doi-asserted-by":"publisher","first-page":"6698","DOI":"10.1038\/s41598-022-10601-5","article-title":"Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomas.","volume":"1","author":"Tang","year":"2022","journal-title":"Sci Rep"},{"key":"3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3389\/fonc.2020.00628","article-title":"Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer.","volume":"1","author":"Turnbull","year":"2020","journal-title":"Front Oncol"},{"key":"4","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1088\/0031-9155\/54\/18\/S02","article-title":"Predicting radiotherapy outcomes using statistical learning techniques.","volume":"5","author":"Deasy","year":"2009","journal-title":"Phys Med Biol"},{"key":"5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.37765\/ajmc.2022.89249","article-title":"Practice radiation patterns among oncologists in the Oncology Care Model.","volume":"2","author":"Robert","year":"2022","journal-title":"Am J Manag Care"},{"key":"6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.nec.2018.08.011","article-title":"Molecular Pathogenesis of Low-Grade Glioma.","volume":"3","author":"Placantonakis","year":"2019","journal-title":"Neurosurg Clin N Am"},{"key":"7","doi-asserted-by":"publisher","first-page":"e6560","DOI":"10.7717\/peerj.6560","article-title":"Identification of differentially expressed key genes between glioblastoma and low-grade glioma by bioinformatics analysis.","volume":"7","author":"Chen","year":"2019","journal-title":"PeerJ"},{"key":"8","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.18632\/aging.204678","article-title":"Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform.","volume":"1","author":"Aliper","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11910-020-01042-6","article-title":"Novel Therapies for Glioblastoma.","volume":"2","author":"Kurz","year":"2020","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/cancers8010015","article-title":"Stress Response Leading to Resistance in Glioblastoma-The Need for Innovative Radiotherapy (iRT) Concepts.","volume":"8","author":"Multhoff","year":"2016","journal-title":"Cancers (Basel)"},{"key":"11","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1186\/1471-2407-14-992","article-title":"INTRAGO: intraoperative radiotherapy in glioblastoma multiforme\u2014a phase I\/II dose escalation study.","volume":"1","author":"Wenz","year":"2014","journal-title":"BMC Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3332\/ecancer.2021.1176","article-title":"Therapeutic strategies of recurrent glioblastoma and its molecular pathways 'Lock up the beast'.","volume":"1","author":"Arafat","year":"2021","journal-title":"Ecancermedicalscience"},{"key":"13","doi-asserted-by":"publisher","first-page":"674596","DOI":"10.3389\/fonc.2021.674596","article-title":"Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and Challenges.","volume":"1","author":"Mueller","year":"2021","journal-title":"Front Oncol"},{"key":"14","doi-asserted-by":"publisher","first-page":"984","DOI":"10.18632\/oncotarget.362","article-title":"PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation.","volume":"2","author":"Cloos","year":"2011","journal-title":"Oncotarget"},{"key":"15","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/ijms22083863","article-title":"The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.","volume":"2","author":"Festuccia","year":"2021","journal-title":"Int J Mol Sci"},{"key":"16","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1039\/d1bm01401c","article-title":"Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies.","volume":"1","author":"Ren","year":"2022","journal-title":"Biomater Sci"},{"key":"17","doi-asserted-by":"publisher","first-page":"10923","DOI":"10.3390\/ijms222010923","article-title":"K-RAS Acts as a Critical Regulator of CD44 to Promote the Invasiveness and Stemness of GBM in Response to Ionizing Radiation.","volume":"2","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2217\/cns.15.25","article-title":"Radiation therapy and grade II\/III oligodendroglial tumors.","volume":"4","author":"Laperriere","year":"2015","journal-title":"CNS Oncol"},{"key":"19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00259-002-0762-0","article-title":"Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas.","volume":"2","author":"Smits","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1017\/s0317167100016838","article-title":"Progress in clinical neurosciences: Advances in the management of low-grade gliomas.","volume":"3","author":"Mason","year":"2005","journal-title":"Can J Neurol Sci"},{"key":"21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform.","volume":"3","author":"Haussler","year":"2020","journal-title":"Nat Biotechnol"},{"key":"22","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1021\/acs.jcim.3c01619","article-title":"PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery.","volume":"6","author":"Zhavoronkov","year":"2024","journal-title":"J Chem Inf Model"},{"key":"23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11060-016-2348-x","article-title":"The role of radiation in treating glioblastoma: here to stay.","volume":"13","author":"Mehta","year":"2017","journal-title":"J Neurooncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3892\/ol.2012.759","article-title":"Response to postoperative radiotherapy as a prognostic factor for patients with low-grade gliomas.","volume":"4","author":"Fijuth","year":"2012","journal-title":"Oncol Lett"},{"key":"25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/02688690701604574","article-title":"Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.","volume":"2","author":"Goel","year":"2007","journal-title":"Br J Neurosurg"},{"key":"26","doi-asserted-by":"publisher","first-page":"100577","DOI":"10.1016\/j.adro.2020.09.017","article-title":"The Association Between Radiation Therapy Dose and Overall Survival in Patients With Intracranial Infiltrative Low-Grade Glioma Treated With Concurrent and\/or Adjuvant Chemotherapy.","volume":"6","author":"Burri","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"27","doi-asserted-by":"publisher","first-page":"1234973","DOI":"10.3389\/fphar.2023.1234973","article-title":"PARP inhibitors combined with radiotherapy: are we ready?","volume":"1","author":"Liu","year":"2023","journal-title":"Front Pharmacol"},{"key":"28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijrobp.2020.02.016","article-title":"Combining Radiation Therapy With Interferons: Back to the Future.","volume":"10","author":"Thijssen","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41016-024-00371-6","article-title":"Knockdown of ATRX enhances radiosensitivity in glioblastoma.","volume":"1","author":"Xu","year":"2024","journal-title":"Chin Neurosurg J"},{"key":"30","doi-asserted-by":"publisher","first-page":"e589","DOI":"10.1016\/j.ijrobp.2021.07.1579","article-title":"ATRXLoss increases sensitivity to proton radiotherapy compared to X-ray radiotherapy in glioma stem cells via secondary necrosis.","volume":"11","author":"Grosshans","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"31","doi-asserted-by":"publisher","first-page":"6234","DOI":"10.1002\/cam4.1862","article-title":"EGFR confers radioresistance in human oropharyngeal carcinoma by activating endoplasmic reticulum stress signaling PERK-eIF2\u03b1-GRP94 and IRE1\u03b1-XBP1-GRP78.","volume":"7","author":"Qiao","year":"2018","journal-title":"Cancer Med"},{"key":"32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pharmthera.2015.07.002","article-title":"EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection.","volume":"15","author":"Lawrence","year":"2015","journal-title":"Pharmacol Ther"},{"key":"33","doi-asserted-by":"publisher","first-page":"912","DOI":"10.4161\/cbt.5.8.3118","article-title":"Long term responses with cetuximab therapy in glioblastoma multiforme.","volume":"5","author":"Bar\u00f3n","year":"2006","journal-title":"Cancer Biol Ther"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T10:13:35Z","timestamp":1740651215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":33,"alternative-id":["206212"],"URL":"https:\/\/doi.org\/10.18632\/aging.206212","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.04.24309952","asserted-by":"object"}]},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}